BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36849451)

  • 1. A Quality Improvement Initiative to Decrease Central Line-Associated Bloodstream Infections During the COVID-19 Pandemic: A "Zero Harm" Approach.
    Redstone CS; Zadeh M; Wilson MA; McLachlan S; Chen D; Sinno M; Khamis S; Malis K; Lui F; Forani S; Scerbo C; Hutton Y; Jacob L; Taher A
    J Patient Saf; 2023 Apr; 19(3):173-179. PubMed ID: 36849451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to minimize central line-associated bloodstream infections in a neonatal intensive care unit: a quality improvement intervention based on a retrospective analysis and the adoption of an evidence-based bundle.
    Bierlaire S; Danhaive O; Carkeek K; Piersigilli F
    Eur J Pediatr; 2021 Feb; 180(2):449-460. PubMed ID: 33083900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradicating central line-associated bloodstream infections statewide: the Hawaii experience.
    Lin DM; Weeks K; Bauer L; Combes JR; George CT; Goeschel CA; Lubomski LH; Mathews SC; Sawyer MD; Thompson DA; Watson SR; Winters BD; Marsteller JA; Berenholtz SM; Pronovost PJ; Pham JC
    Am J Med Qual; 2012; 27(2):124-9. PubMed ID: 21918016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing central line-associated bloodstream infections in North Carolina NICUs.
    Fisher D; Cochran KM; Provost LP; Patterson J; Bristol T; Metzguer K; Smith B; Testoni D; McCaffrey MJ
    Pediatrics; 2013 Dec; 132(6):e1664-71. PubMed ID: 24249819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line-associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic.
    Ben-Aderet MA; Madhusudhan MS; Haroun P; Almario MJP; Raypon R; Fawcett S; Johnson J; Girard A; Griner T; Sheffield L; Grein JD
    Infect Control Hosp Epidemiol; 2023 Jul; 44(7):1108-1115. PubMed ID: 36043349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidisciplinary intervention to reduce central line-associated bloodstream infection in pediatrics and neonatal intensive care units.
    Hamza WS; Hamed EAM; Alfadhli MA; Ramadan MA
    Pediatr Neonatol; 2022 Jan; 63(1):71-77. PubMed ID: 34620576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From kamishibai card to key card: a family-targeted quality improvement initiative to reduce paediatric central line-associated bloodstream infections.
    Kamity R; Grella M; Kim ML; Akerman M; Quintos-Alagheband ML
    BMJ Qual Saf; 2021 Jan; 30(1):72-81. PubMed ID: 32636211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with international prevention guidelines for central-line-associated bloodstream infections in neonatal intensive care units in Belgium: a national survey.
    Mahieu L; Van Damme K; Mertens K; Pierart J; Tackoen M; Cossey V
    J Hosp Infect; 2022 Nov; 129():49-57. PubMed ID: 35944792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Descriptive epidemiology of central line-associated bloodstream infections at an academic medical center in Iowa, 2019-2022.
    Harrington EM; Trautman K; Davis MB; Varzavand K; Meacham H; Dains A; Marra AR; McDanel J; Kenne L; Hanna B; Murphy JP; Diekema DJ; Wellington M; Brust KB; Kobayashi T; Abosi OJ
    Am J Infect Control; 2024 Apr; 52(4):436-442. PubMed ID: 37827243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid cycle development of a multifactorial intervention achieved sustained reductions in central line-associated bloodstream infections in haematology oncology units at a children's hospital: a time series analysis.
    Dandoy CE; Hausfeld J; Flesch L; Hawkins D; Demmel K; Best D; Osterkamp E; Bracke T; Nagarajan R; Jodele S; Holt J; Giaccone MJ; Davies SM; Kotagal U; Simmons J
    BMJ Qual Saf; 2016 Aug; 25(8):633-43. PubMed ID: 26608456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bundle approach used to achieve zero central line-associated bloodstream infections in an adult coronary intensive care unit.
    Gupta P; Thomas M; Patel A; George R; Mathews L; Alex S; John S; Simbulan C; Garcia ML; Al-Balushi S; El Hassan M
    BMJ Open Qual; 2021 Feb; 10(1):. PubMed ID: 33597274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the rate of central line-associated bloodstream infections; a quality improvement project.
    Odada D; Munyi H; Gatuiku J; Thuku R; Nyandigisi J; Wangui A; Ashihundu E; Nyakiringa B; Kimeu J; Musumbi M; Adam RD
    BMC Infect Dis; 2023 Oct; 23(1):745. PubMed ID: 37904103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quality improvement initiative to reduce central line infection in neonates using checklists.
    Taylor JE; McDonald SJ; Earnest A; Buttery J; Fusinato B; Hovenden S; Wallace A; Tan K
    Eur J Pediatr; 2017 May; 176(5):639-646. PubMed ID: 28283785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts.
    Fakih MG; Bufalino A; Sturm L; Huang RH; Ottenbacher A; Saake K; Winegar A; Fogel R; Cacchione J
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):26-31. PubMed ID: 33602361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates.
    Álvarez-Moreno CA; Valderrama-Beltrán SL; Rosenthal VD; Mojica-Carreño BE; Valderrama-Márquez IA; Matta-Cortés L; Gualtero-Trujillo SM; Rodríguez-Peña J; Linares-Miranda CJ; Gonzalez-Rubio ÁP; Vega-Galvis MC; Riaño-Forero I; Ariza-Ayala BE; García-Laverde G; Susmann O; Mancera-Páez O; Olarte N; Rendón-Campo LF; Astudillo Y; Trullo-Escobar MD; Orellano PW
    Am J Infect Control; 2016 Nov; 44(11):e235-e241. PubMed ID: 27317408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of COVID-19 hospitalization rates on the incidence of hospital-acquired Candida central line-associated bloodstream infection.
    Ford D; Reveles K; Hoban C; Koutoubi S; Cadena J
    Am J Infect Control; 2024 Apr; 52(4):387-391. PubMed ID: 37813280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of central line-associated bloodstream infections in a pediatric hematology/oncology population.
    Wilson MZ; Deeter D; Rafferty C; Comito MM; Hollenbeak CS
    Am J Med Qual; 2014; 29(6):484-90. PubMed ID: 24226650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing ambulatory central line-associated bloodstream infections: A family-centered approach.
    Wong CI; Ilowite M; Yan A; Mahan RM; Desrochers MD; Conway M; Billett AL
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31064. PubMed ID: 38761026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimizing central line-associated bloodstream infections in a high-acuity liver transplant intensive care unit.
    Russell TA; Fritschel E; Do J; Donovan M; Keckeisen M; Agopian VG; Farmer DG; Wang T; Rubin Z; Busuttil RW; Kaldas FM
    Am J Infect Control; 2019 Mar; 47(3):305-312. PubMed ID: 30333081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing CLABSIs in an Adult Cardiothoracic ICU.
    Orozco-Santana E; Fowlds T; Tamayo M; Jew C; Young P; Sheehan P; Murray K; Marcarian T
    Am J Nurs; 2023 May; 123(5):43-49. PubMed ID: 37077018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.